Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure
Description
CONCLUSION: Compared to low dose tocilizumab, the high dose did not provide additional efficacy and mortality benefit but resulted in higher fungal and viral infections. This study illustrates that low dose tocilizumab can be an alternative to high
